{"DataElement":{"publicId":"5042526","version":"1","preferredName":"Disease or Disorder Solitary Plasmacytoma Risk Assessment Category","preferredDefinition":"The category used to describe risk assessment of a subject with solitary plasmacytoma.","longName":"PLASMACYTOMARISKCAT","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"5042519","version":"1","preferredName":"Disease or Disorder Solitary Plasmacytoma Risk Assessment","preferredDefinition":"Information related to the risk assessment of a subject with solitary plasmacytoma.","longName":"PLASMACYTOMARISK","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5042517","version":"1","preferredName":"Solitary Plasmacytoma Risk Assessment","preferredDefinition":"A localized clonal (malignant) plasma cell infiltrate either in the bone or in another anatomic site without peripheral blood involvement.:The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.:The final result of a determination of the value, significance, or extent of.","longName":"C6932:C17102:C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Solitary Plasmacytoma","conceptCode":"C6932","definition":"A localized malignant neoplasm that arises in the bony skeleton or soft tissue. It is composed of clonal (malignant) plasma cells forming a tumor mass.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Risk","conceptCode":"C17102","definition":"The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23BB3AE5-C65B-8DFD-E050-BB89AD432B1E","latestVersionIndicator":"Yes","beginDate":"2015-11-04","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2015-11-04","modifiedBy":"ONEDATA","dateModified":"2015-11-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23BB3AE5-C66C-8DFD-E050-BB89AD432B1E","latestVersionIndicator":"Yes","beginDate":"2015-11-04","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2015-11-04","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5042520","version":"1","preferredName":"Solitary Plasmacytoma Risk Category","preferredDefinition":"A grouping of items based on some commonality or by user defined characteristics.","longName":"PLASMACYTOMARISKCAT","context":"Alliance","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"% of abnormal plasma cells in the bone marrow 5-9%","valueDescription":"% of abnormal plasma cells in the bone marrow 5-9%","ValueMeaning":{"publicId":"5042521","version":"1","preferredName":"% of abnormal plasma cells in the bone marrow 5-9%","longName":"5042521","preferredDefinition":"% of abnormal plasma cells in the bone marrow 5-9%","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23BB3AE5-C692-8DFD-E050-BB89AD432B1E","latestVersionIndicator":"Yes","beginDate":"2015-11-04","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2015-11-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23BB3AE5-C6AB-8DFD-E050-BB89AD432B1E","beginDate":"2015-11-04","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2015-11-04","modifiedBy":"ONEDATA","dateModified":"2015-11-04","deletedIndicator":"No"},{"value":"Age >=60 AND % of abnormal plasma cells in the bone marrow <5% AND monoclonal protein present in the blood or urine","valueDescription":"Age >=60 AND % of abnormal plasma cells in the bone marrow <5% AND monoclonal protein present in the blood or urine","ValueMeaning":{"publicId":"5042523","version":"1","preferredName":"Age >=60 AND % of abnormal plasma cells in the bone marrow <5% AND monoclonal protein present in the blood or urine","longName":"5042523","preferredDefinition":"Age >=60 AND % of abnormal plasma cells in the bone marrow <5% AND monoclonal protein present in the blood or urine","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23BB3AE5-C6D8-8DFD-E050-BB89AD432B1E","latestVersionIndicator":"Yes","beginDate":"2015-11-04","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2015-11-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23BB3AE5-C6F1-8DFD-E050-BB89AD432B1E","beginDate":"2015-11-04","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2015-11-04","modifiedBy":"ONEDATA","dateModified":"2015-11-04","deletedIndicator":"No"},{"value":"Age <60 AND % of abnormal plasma cells in the bone marrow <5% AND no monoclonal protein present in the blood or urine AND MRD+","valueDescription":"Age <60 AND % of abnormal plasma cells in the bone marrow <5% AND no monoclonal protein present in the blood or urine AND MRD+","ValueMeaning":{"publicId":"5042524","version":"1","preferredName":"Age <60 AND % of abnormal plasma cells in the bone marrow <5% AND no monoclonal protein present in the blood or urine AND MRD+","longName":"5042524","preferredDefinition":"Age <60 AND % of abnormal plasma cells in the bone marrow <5% AND no monoclonal protein present in the blood or urine AND MRD+","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23BB3AE5-C6FB-8DFD-E050-BB89AD432B1E","latestVersionIndicator":"Yes","beginDate":"2015-11-04","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2015-11-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23BB3AE5-C714-8DFD-E050-BB89AD432B1E","beginDate":"2015-11-04","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2015-11-04","modifiedBy":"ONEDATA","dateModified":"2015-11-04","deletedIndicator":"No"},{"value":"Age <60 AND % of abnormal plasma cells in the bone marrow <5% AND monoclonal protein present in the blood or urine","valueDescription":"Age <60 AND % of abnormal plasma cells in the bone marrow <5% AND monoclonal protein present in the blood or urine","ValueMeaning":{"publicId":"5042525","version":"1","preferredName":"Age <60 AND % of abnormal plasma cells in the bone marrow <5% AND monoclonal protein present in the blood or urine","longName":"5042525","preferredDefinition":"Age <60 AND % of abnormal plasma cells in the bone marrow <5% AND monoclonal protein present in the blood or urine","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23BB3AE5-C71E-8DFD-E050-BB89AD432B1E","latestVersionIndicator":"Yes","beginDate":"2015-11-04","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2015-11-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23BB3AE5-C737-8DFD-E050-BB89AD432B1E","beginDate":"2015-11-04","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2015-11-04","modifiedBy":"ONEDATA","dateModified":"2015-11-04","deletedIndicator":"No"},{"value":"Age >=60 AND % of abnormal plasma cells in the bone marrow <5% AND no monoclonal protein present in the blood or urine AND MRD+","valueDescription":"Age >=60 AND % of abnormal plasma cells in the bone marrow <5% AND no monoclonal protein present in the blood or urine AND MRD+","ValueMeaning":{"publicId":"5043712","version":"1","preferredName":"Age >=60 AND % of abnormal plasma cells in the bone marrow <5% AND no monoclonal protein present in the blood or urine AND MRD+","longName":"5043712","preferredDefinition":"Age >=60 AND % of abnormal plasma cells in the bone marrow <5% AND no monoclonal protein present in the blood or urine AND MRD+","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24342D80-6B36-16D6-E050-BB89AD4321A1","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24342D80-6B4F-16D6-E050-BB89AD4321A1","beginDate":"2015-11-04","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2015-11-10","modifiedBy":"ONEDATA","dateModified":"2015-11-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23BB3AE5-C67E-8DFD-E050-BB89AD432B1E","latestVersionIndicator":"Yes","beginDate":"2015-11-04","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2015-11-04","modifiedBy":"ZIEGLERK","dateModified":"2015-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Risk group","type":"Preferred Question Text","description":"Risk group","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23BB3AE5-C741-8DFD-E050-BB89AD432B1E","latestVersionIndicator":"Yes","beginDate":"2015-11-04","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2015-11-04","modifiedBy":"ZIEGLERK","dateModified":"2015-11-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}